Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hemolytic effect of copper complexes with different ligands.

D Dimitrova1, N Radonova, E Ivancheva

  • 1Institute of Physiology, Bulgarian Academy of Sciences, Sofia.

Acta Physiologica Et Pharmacologica Bulgarica
|January 1, 1987
PubMed
Summary

Copper(II) complexes induce hemolysis and hemoglobin oxidation in erythrocytes. This effect is mitigated by complexons, albumin, histidine, and antioxidants, suggesting redox involvement and potential for parenteral applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is pregnancy feasible in women with adult granulosa cell tumors, and how should recurrence during pregnancy be managed? A case report and literature review.

Gynecologic oncology reports·2026
Same author

Severe hemorrhage in choriocarcinoma: three scenarios and treatment strategies.

Gynecologic oncology reports·2025
Same author

Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

Blood·2022
Same author

Risk factors and outcomes associated with type of uterine rupture.

Archives of gynecology and obstetrics·2022
Same author

Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patients.

Archives of gynecology and obstetrics·2021
Same author

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany.

BMC cancer·2021

Area of Science:

  • Biochemistry and Toxicology
  • Redox Biology
  • Erythrocyte Membrane Studies

Background:

  • Copper(II) ions and their complexes are known to interact with biological systems.
  • Understanding the erythrocyte response to metal complexes is crucial for assessing toxicity and therapeutic potential.
  • Hemolysis and hemoglobin denaturation are key indicators of cellular damage.

Purpose of the Study:

  • To investigate the hemolytic effects of specific Copper(II) complexes on rat and human erythrocytes.
  • To elucidate the mechanisms underlying Copper(II) complex-induced erythrocyte damage, including hemoglobin oxidation and precipitation.
  • To explore the potential for parenteral application of these Copper(II) complexes by assessing factors that mitigate their adverse effects.

Main Methods:

Related Experiment Videos

  • Incubation of erythrocytes with varying concentrations and durations of Copper(II) and its complexes (Cu(II)(cimetidine)2, Cu(II)(glycine), Cu(II)(glycine)2).
  • Assays for hemolysis, hemoglobin oxidation, and denatured hemoglobin precipitate formation.
  • Evaluation of protective effects using strong complexons, albumin, histidine, a Cu(I) chelator, and superoxide dismutase.

    • Main Results:

    • Copper(II) complexes induced dose- and time-dependent hemolysis, hemoglobin oxidation, and precipitate formation.
    • Hemolytic effects were significantly reduced by strong complexons, albumin, and histidine.
    • The presence of a Cu(I) chelator and superoxide dismutase markedly decreased hemolysis, indicating a role for redox transitions and superoxide radicals.

    Conclusions:

    • Copper(II) complexes exert significant hemolytic and oxidative effects on erythrocytes.
    • The observed effects are mediated by redox reactions involving Copper(II) and superoxide.
    • The findings provide insights into the stability and reactivity of different Copper(II) complexes, informing their potential for parenteral administration.